People with obesity are more likely to develop a rapid and irregular heart rate, called atrial fibrillation, which can lead to stroke, heart failure and other complications. This is according to Penn State researchers who followed a large group of participants, equally divided between people with obesity and without, for eight years. They found that people with obesity had a 40% higher chance of developing atrial fibrillation than people without obesity.
Dr Andrew Foy, assistant professor of medicine, Penn State College of Medicine, said the results suggest that for patients with both obesity and atrial fibrillation, losing weight has the potential to help treat and manage their atrial fibrillation.
“If you have both atrial fibrillation and obesity, treating obesity will go a long way in treating and managing your atrial fibrillation,” Foy said. “And if you have obesity, and lose weight through diet, exercise, or even surgery, that will help reduce your risk of developing chronic conditions like atrial fibrillation.”
Atrial fibrillation happens when the electrical currents in the heart go haywire and the top chambers of the heart quiver or flutter. The condition puts patients at a higher risk for developing other heart complications, and also puts a strain on the healthcare system due to the medications, procedures and possible hospitalizations needed to manage the condition.
While previous research has linked obesity and atrial fibrillation, Foy said he wanted to explore the connection in a larger sample of younger patients. He and the other researchers followed a group of 67,278 patients – half with obesity and half without – for eight years. The average participant age was 43.8 and nearly 77% were women.
After analysing the data, the researchers found that while 1.8% of the patients without obesity developed atrial fibrillation, 2.7% of the patients with obesity developed the condition. They also found that people with obesity are almost just as likely to develop atrial fibrillation as people with hypertension or diabetes.
According to the study, people with obesity are 40% more likely to develop atrial fibrillation, while they are 45% and 51% more likely to develop hypertension or diabetes, respectively.
Foy said the association could possibly be explained by the stress and strain put on the heart by obesity. “When the heart is strained, it can lead to changes in the atrium – the top chambers of the heart – and it’s here where we believe structural abnormalities can precipitate atrial fibrillation,” Foy said. “Patients with obesity tend to have more fibrosis, higher pressures and more fatty infiltration in the top chamber of their hearts, so atrial fibrillation could be related to these types of changes.”
Dr Gerald Naccarelli, professor of medicine and chief of the division of cardiology, Penn State College of Medicine, said the results could help physicians better evaluate and communicate with their patients.
“Practitioners should counsel their obese patients to look for symptoms of atrial fibrillation, such as palpitations, shortness of breath and weakness and encourage them to lose weight,” Naccarelli said. “In addition, practitioners have to look for other risk factors that are more common in obese patients such as diabetes, hypertension or coronary artery disease.”
Foy said the study also underscores the importance of treating obesity in patients regardless of whether they’ve developed complications.
“We have lots of interventions aimed at treating hypertension, but we don’t really have the same when it comes to obesity,” Foy said. “We know that obesity is a problem, but we need to be as serious about the management, prevention and treatment of the obesity crisis as we are about conditions like hypertension and diabetes.”
John Mandrola, cardiologist, Baptist Health Louisville; and Guodong Liu, assistant professor of public health sciences, Penn State College of Medicine, also participated in this research.
Prospective cohort studies involving older adults report an association of obesity and new-onset atrial fibrillation and atrial flutter. To assess this relation, we performed a longitudinal cohort study from January 1, 2006 to December 31, 2013, using a national claims database that tracks all inpatient, outpatient, and pharmacy claims data. The primary end point of new-onset atrial fibrillation was compared between obese and non-obese cohorts. We used logistic regression to determine the strength of association between obesity and new-onset atrial fibrillation controlling for age, gender, hypertension, and diabetes. Overall, 67,278 subjects were included in the cohort, divided evenly between those with and without a diagnosis of obesity. Obese subjects were significantly more likely to have hypertension (29.5% vs 14.6%) and diabetes (12.7% vs 5.2%) at study onset. Over 8 years of follow-up, we recorded a new diagnosis of atrial fibrillation in 1,511 (2.2%) subjects. Obesity was strongly associated with a new diagnosis of atrial fibrillation after controlling for age, gender, hypertension, and diabetes (odds ratio 1.4, 95% confidence interval 1.3 to 1.6). In conclusion, this information contributes to the growing evidence supporting the causal relation between obesity and atrial fibrillation and emphasizes the need of addressing obesity as part of our therapeutic strategy to prevent atrial fibrillation.
Andrew J Foy, John Mandrola, Guodong Liu, Gerald V Naccarelli